Raymond James & Associates’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,428
Closed -$114K 4020
2024
Q2
$114K Sell
16,428
-6,760
-29% -$91K ﹤0.01% 3715
2024
Q1
$410K Buy
23,188
+5,707
+33% +$90.4K ﹤0.01% 3189
2023
Q4
$271K Sell
17,481
-4,260
-20% -$55.7K ﹤0.01% 3343
2023
Q3
$298K Buy
21,741
+658
+3% +$9.69K ﹤0.01% 3230
2023
Q2
$364K Sell
21,083
-10,203
-33% -$209K ﹤0.01% 3125
2023
Q1
$751K Sell
31,286
-30,246
-49% -$658K ﹤0.01% 2649
2022
Q4
$1.07M Buy
61,532
+46,681
+314% +$984K ﹤0.01% 2391
2022
Q3
$362K Sell
14,851
-1,815
-11% -$62.5K ﹤0.01% 3061
2022
Q2
$516K Sell
16,666
-472
-3% -$12.6K ﹤0.01% 2895
2022
Q1
$598K Sell
17,138
-12,640
-42% -$478K ﹤0.01% 2960
2021
Q4
$1.76M Buy
29,778
+182
+0.6% +$12.6K ﹤0.01% 2263
2021
Q3
$1.97M Sell
29,596
-6,269
-17% -$387K ﹤0.01% 2115
2021
Q2
$2.26M Sell
35,865
-1,409
-4% -$79.3K ﹤0.01% 2017
2021
Q1
$1.94M Buy
37,274
+10,467
+39% +$637K ﹤0.01% 2035
2020
Q4
$1.18M Buy
26,807
+14,684
+121% +$699K ﹤0.01% 2232
2020
Q3
$575K Buy
+12,123
New +$491K ﹤0.01% 2517

Other funds holding CYRX

Raymond James & Associates's CYRX Position: Q3 2024 in Review

Raymond James & Associates sold out of CryoPort (CYRX) in Q3 2024, closing a stake of 16,428 shares — an estimated $114K sold.

Raymond James & Associates first reported a position in CYRX in Q3 2020 and held it in 16 quarters. The position peaked at $2.26M in Q2 2021. 152 funds tracked by Wall St. Rank hold CYRX as of Q3 2024.

  • Raymond James & Associates reported no remaining CryoPort position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 16,428 CryoPort shares in Q3 2024, an estimated $114K.
  • Raymond James & Associates first reported a position in CryoPort in Q3 2020 and held it in 16 quarters.
  • Raymond James & Associates's CryoPort position peaked at $2.26M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held CryoPort as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.